QCOR Share Price

Open 91.50 Change Price %
High 91.78 1 Day -1.12 -1.22
Low 89.92 1 Week 0.00 0.00
Close 90.64 1 Month 0.00 0.00
Volume 1523852 1 Year 0.00 0.00
52 Week High 71.62
52 Week Low 42.24
QCOR Important Levels
Resistance 2 92.36
Resistance 1 91.65
Pivot 90.78
Support 1 89.63
Support 2 88.92
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR)

QCOR Technical Analysis 2
As on 12th Aug 2014 QCOR Share Price closed @ 90.64 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 72.00 & Sell for SHORT-TERM with Stoploss of 91.85 we also expect STOCK to react on Following IMPORTANT LEVELS.
QCOR Target for December
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
QCOR Other Details
Segment EQ
Market Capital 1458947840.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.questcor.com
QCOR Address
QCOR
1300 North Kellogg Drive
Suite D
Anaheim, CA 92807
United States
Phone: 714-786-4200
Fax: 714-789-4229
QCOR Latest News
Interactive Technical Analysis Chart Questcor Pharmaceuticals, Inc. ( QCOR NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Questcor Pharmaceuticals, Inc.
QCOR Business Profile
Questcor Pharmaceuticals, Inc. (Questcor) is a biopharmaceutical company. The Company is focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. Its primary product is H.P. Acthar Gel (repository corticotropin injection), or Acthar, an injectable drug that is approved by the United States food and drug administration (FDA), for the treatment of 19 indications. Its research and development program is focused on: the evaluation of the use of Acthar for certain on-label indications; the investigation of other potential uses of Acthar for indications not FDA approved; and the expansion of its understanding of how Acthar works in the human body (pharmacology), and ultimately, its mechanisms of action in the disease states for which it is used, or may be used in the future. The Company sells Doral to pharmaceutical wholesalers, which resell Doral primarily to retail pharmacies and hospitals.